Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
erectile-dysfunction-drugs-market

Erectile Dysfunction Drugs Market [By Product (Viagra (Sildenafil citrate), Cialis (tadalafil), Levitra/Staxyn (vardenafil), Stendra/Spedra (avanafil), Zydena (udenafil), Vitaros (Alprostadil Cream), and Others), By Component Type (Testosterone, Phosphodiestarse - 5 Inhibitors (PDE5I), Alprostadil, and others); Dosage Form (Topical Dose, Oral Dose, Injection and others); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies); By Regions]: Market Size& Forecast, 2017 – 2025

Published: Jan 2018
Pages: 60
Format: PDF
Report ID: PM1063
License and Pricing
Buy Now Inquire Before Buying

Report Summary

The worldwide market size for erectile dysfunction drugs market was estimated to be at USD 2.49 billion in 2017. The erectile dysfunction or impotence is characterized by inability to sustain or build up a penile erection during sexual intercourse. According to World Health Organization statement, for the emotional, physical and wellbeing of the individual, and to the economic and social development of countries and communities, sexual health is a fundamental thing. The common causes of erectile dysfunction engage side effects of medicines, neurogenic disorders, aging, multiple sclerosis, psychological causes, and diabetes, and lifestyle changes.

The increasing elderly population and high rate of chronic diseases such as kidney failure, diabetes, hypertension, hormonal imbalance, and neurological disorders are increasing demand for erectile dysfunction drugs globally. Moreover, rising awareness among patients about erectile dysfunction and availability of treatment are contributing significantly towards the growth of erectile dysfunction drugs market globally. But, even with of rising demand for erectile dysfunction drugs, the global market is facing decline owing to patent expiry of market blockbuster drugs such as Viagra etc. On the contrary, the patent expiration of major brands is generating major opportunity for generic manufacturers to enter in the erectile dysfunction drugs market. Moreover, players in various stages of pipeline are also expected to generate huge opportunity for global erectile dysfunction drugs market globally.

North America Erectile dysfunction drugs Market by Product, 2017 - 2025

North America Erectile dysfunction drugs Market by Product, 2017 - 2025

Note: Inside circle depicts data for 2017 & outside circle depicts data for 2026

Segment Analysis

The global market for erectile dysfunction drugs is segmented by the product, component type, dosage form, end user, and geographically. On the basis of product, the global erectile dysfunction market is segmented into Viagra (Sildenafil citrate), Cialis (tadalafil), Levitra/Staxyn (vardenafil), Stendra/Spedra (avanafil), Zydena (udenafil), Vitaros (Alprostadil Cream), and Others. By component type, the global erectile dysfunction market is further segmented into Testosterone, Phosphodiestarse - 5 Inhibitors (PDE5I), Alprostadil, and others. The Phosphodiestarse - 5 Inhibitors drugs are widely prescribed drugs to treat erectile dysfunction and hence accounted major share in global erectile dysfunction drugs market. Sildenafil, Vardenafil, Tadalafil, Avanafil, Udenafil are the mostly used drugs of Phosphodiestarse - 5 Inhibitors. Oral PDE inhibitors are an efficacious, convenient, and widely available treatment choice for erectile dysfunction. These drugs inhibit type 5 PDE inside the cavernosal smooth muscle and avoid the breakdown of cGMP to GMP. The nitric oxide mediated smooth muscle relaxation is therefore facilitated in both the cavernosal arteries and corpus cavernosum. sildenafil, tadalafil, and vardenafil  are the three main PDE-5 inhibitors effective in a wide range of patient groups.

By dosage form, the global erectile dysfunction market is further sub segmented into topical, oral, injections, and others. The oral segment accounted major share in global erectile dysfunction drugs market. The injections are injected in penis. The injection causes the muscle relaxation of penis and encourages blood to flow into penis. The topical drugs are applied over the body.

SAMPLE TABLE
North America Erectile dysfunction drugs Market, By Product, 2017 - 2025 
(USD Million)

North America Erectile dysfunction drugs Market, By Product, 2017 - 2025 (USD Million)

On the basis of distribution channel, the global erectile dysfunction drugs market is further segmented into, hospital pharmacies, retail pharmacies, online pharmacies, and drug stores. By distribution channel, retail pharmacies accounted major share in global erectile dysfunction drugs market. The easy availability of drugs and large number of retail pharmacies are the factors contributed towards the large share of segment in the global market. The online pharmacies segment is expected to register high growth over the forecast period. The rising online pharmacies globally are expected to drive the growth of segment in global erectile dysfunction drugs market globally

Regional Analysis

By geography, the global erectile dysfunction drugs market is segmented into five major regions, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America counted major share in global erectile dysfunction drugs market. The high awareness among the people about the erectile dysfunction, prolongation of patent exclusivity rights for Viagra in U.S. and presence of large number of players in the region are the key factors contributed towards high market share in the global erectile dysfunction drugs market. The Asia Pacific is expected to grow at high rate in the coming years owing to accelerated economical growth; increasing aging population, and increasing awareness, is expected to propel the growth of region over the forecast period.

Competitive Landscape

The key players in the erectile dysfunction drugs market include Bayer AG, Pfizer, Eli Lilly & Co., Vivus, Inc., S.K. Chemicals Co. Ltd., Dong-A Pharmaceutical Co. Ltd, Meda Pharmaceuticals, Apricus Biosciences, Vivus, Inc. among others.

Key questions answered by the report

  • What is the current market size and forecasts of erectile dysfunction drugs
  • What is the market opportunity for erectile dysfunction by Product
  • What is the market opportunity for erectile dysfunction by component type
  • What is the market opportunity for erectile dysfunction drugs by dosage form
  • What is the market opportunity for erectile dysfunction drugs distribution channel
  • How much is the estimated market for erectile dysfunction drugs in North America and Asia Pacific during the forecast period.
  • What are the companies in this market and how are they classified.
  • What are the available opportunities and who are the top market players in this
  • What are the major drivers and challenges of global erectile dysfunction drugs market
  • Which are the major distribution channel segments and what traction are they gaining in the market.

Table of Contents

  1. Overview and Scope
    1. Research goal & scope
    2. Research assumptions
    3. Research Methodology
      1. Primary data sources
      2. Secondary data sources
    4. Key take-aways
    5. Stakeholders
  2. Executive Summary
    1. Market Definition
    2. Market Segmentation
  3. Erectile dysfunction drugs Market Insights
    1. Erectile dysfunction drugs– Industry snapshot
    2. Erectile dysfunction drugs -Ecosystem analysis
    3. Erectile dysfunction drugs market dynamics
      1. Erectile dysfunction drugs– Market Forces
        1. Erectile dysfunction drugs Market driver analysis
        2. Erectile dysfunction drugs Market restraint/challenges analysis
        3. Erectile dysfunction drugs Market opportunity analysis
      2. Industry analysis - Porter's five force
        1. Bargaining power of supplier
        2. Bargaining power of buyer
        3. Threat of substitute
        4. Threat of new entrant
        5. Degree of competition
      3. Erectile dysfunction drugs market PEST analysis, 2017
      4. Value Chain Analysis
      5. Erectile dysfunction drugs Industry trends
      6. Prevalence of erectile dysfunction
  4. Erectile Dysfunction Drugs Market Size and Forecast by Product
    1. Key findings
    2. Viagra (Sildenafil citrate)
      1. Global market estimates and forecasts, 2017 – 2025
    3. Cialis (tadalafil)
      1. Global market estimates and forecasts, 2017 – 2025
    4. Levitra/Staxyn (vardenafil)
      1. Global market estimates and forecasts, 2017 – 2025
    5. Stendra/Spedra (avanafil)
      1. Global market estimates and forecasts, 2017 – 2025
    6. Zydena (udenafil)
      1. Global market estimates and forecasts, 2017 – 2025
    7. Vitaros (Alprostadil Cream)
      1. Global market estimates and forecasts, 2017 – 2025
    8. Others
      1. Global market estimates and forecasts, 2017 – 2025
  5. Erectile Dysfunction Drugs Market Size and Forecast by Component Type
    1. Key findings
    2. Testosterone
      1. Global market estimates and forecasts, 2017 – 2025
    3. Phosphodiestarse - 5 Inhibitors (PDE5I)
      1. Global market estimates and forecasts, 2017 – 2025
    4. Alprostadil
      1. Global market estimates and forecasts, 2017 – 2025
    5. Others
      1. Global market estimates and forecasts, 2017 – 2025
  6. Erectile Dysfunction Drugs Market Size and Forecast by Dosage Form
    1. Key findings
    2. Oral
      1. Global market estimates and forecasts, 2017 – 2025
    3. Topical
      1. Global market estimates and forecasts, 2017 – 2025
    4. Injections
      1. Global market estimates and forecasts, 2017 – 2025
    5. Others
      1. Global market estimates and forecasts, 2017 – 2025
  7. Erectile Dysfunction Drugs Market Size and Forecast by Distribution Channel
    1. Key findings
    2. Hospital Pharmacy
      1. Global market estimates and forecasts, 2017 - 2025
    3. Retail Pharmacy
      1. Global market estimates and forecasts, 2017 – 2025
    4. Online Pharmacy
      1. Global market estimates and forecasts, 2017 - 2025
  8. Erectile Dysfunction Drugs Market Size and Forecast by Regions
    1. Key findings
    2. North America
      1. Erectile Dysfunction Drugs Market by Product (USD Million), 2017 - 2025
      2. Erectile Dysfunction Drugs Market by Component type (USD Million), 2017 - 2025
      3. Erectile Dysfunction Drugs Market by Dosage Form (USD Million), 2017 - 2025
      4. Erectile Dysfunction Drugs Market by Distribution Channel (USD Million), 2017 - 2025
      5. U.S.
        1. Erectile Dysfunction Drugs Market by Product (USD Million), 2017 - 2025
        2. Erectile Dysfunction Drugs Market by Component type (USD Million), 2017 - 2025
        3. Erectile Dysfunction Drugs Market by Dosage Form (USD Million), 2017 - 2025
        4. Erectile Dysfunction Drugs Market by Distribution Channel (USD Million), 2017 - 2025
      6. Canada
        1. Erectile Dysfunction Drugs Market by Product (USD Million), 2017 - 2025
        2. Erectile Dysfunction Drugs Market by Component type (USD Million), 2017 - 2025
        3. Erectile Dysfunction Drugs Market by Dosage Form (USD Million), 2017 - 2025
        4. Erectile Dysfunction Drugs Market by Distribution Channel (USD Million), 2017 - 2025
      7. Mexico
        1. Erectile Dysfunction Drugs Market by Product (USD Million), 2017 - 2025
        2. Erectile Dysfunction Drugs Market by Component type (USD Million), 2017 - 2025
        3. Erectile Dysfunction Drugs Market by Dosage Form (USD Million), 2017 - 2025
        4. Erectile Dysfunction Drugs Market by Distribution Channel (USD Million), 2017 - 2025
    3. Europe
      1. Erectile Dysfunction Drugs Market by Product (USD Million), 2017 - 2025
      2. Erectile Dysfunction Drugs Market by Component type (USD Million), 2017 - 2025
      3. Erectile Dysfunction Drugs Market by Dosage Form (USD Million), 2017 - 2025
      4. Erectile Dysfunction Drugs Market by Distribution Channel (USD Million), 2017 - 2025
      5. Germany
        1. Erectile Dysfunction Drugs Market by Product (USD Million), 2017 - 2025
        2. Erectile Dysfunction Drugs Market by Component type (USD Million), 2017 - 2025
        3. Erectile Dysfunction Drugs Market by Dosage Form (USD Million), 2017 - 2025
        4. Erectile Dysfunction Drugs Market by Distribution Channel (USD Million), 2017 - 2025
      6. UK
        1. Erectile Dysfunction Drugs Market by Product (USD Million), 2017 - 2025
        2. Erectile Dysfunction Drugs Market by Component type (USD Million), 2017 - 2025
        3. Erectile Dysfunction Drugs Market by Dosage Form (USD Million), 2017 - 2025
        4. Erectile Dysfunction Drugs Market by Distribution Channel (USD Million), 2017 - 2025
    4. Asia Pacific
      1. Erectile Dysfunction Drugs Market by Product (USD Million), 2017 - 2025
      2. Erectile Dysfunction Drugs Market by Component type (USD Million), 2017 - 2025
      3. Erectile Dysfunction Drugs Market by Dosage Form (USD Million), 2017 - 2025
      4. Erectile Dysfunction Drugs Market by Distribution Channel (USD Million), 2017 - 2025
      5. China
        1. Erectile Dysfunction Drugs Market by Product (USD Million), 2017 - 2025
        2. Erectile Dysfunction Drugs Market by Component type (USD Million), 2017 - 2025
        3. Erectile Dysfunction Drugs Market by Dosage Form (USD Million), 2017 - 2025
        4. Erectile Dysfunction Drugs Market by Distribution Channel (USD Million), 2017 - 2025
      6. India
        1. Erectile Dysfunction Drugs Market by Product (USD Million), 2017 - 2025
        2. Erectile Dysfunction Drugs Market by Component type (USD Million), 2017 - 2025
        3. Erectile Dysfunction Drugs Market by Dosage Form (USD Million), 2017 - 2025
        4. Erectile Dysfunction Drugs Market by Distribution Channel (USD Million), 2017 - 2025
      7. Japan
        1. Erectile Dysfunction Drugs Market by Product (USD Million), 2017 - 2025
        2. Erectile Dysfunction Drugs Market by Component type (USD Million), 2017 - 2025
        3. Erectile Dysfunction Drugs Market by Dosage Form (USD Million), 2017 - 2025
        4. Erectile Dysfunction Drugs Market by Distribution Channel (USD Million), 2017 - 2025
    5. Latin America
      1. Erectile Dysfunction Drugs Market by Product (USD Million), 2017 - 2025
      2. Erectile Dysfunction Drugs Market by Component type (USD Million), 2017 - 2025
      3. Erectile Dysfunction Drugs Market by Dosage Form (USD Million), 2017 - 2025
      4. Erectile Dysfunction Drugs Market by Distribution Channel (USD Million), 2017 - 2025
      5. Brazil
        1. Erectile Dysfunction Drugs Market by Product (USD Million), 2017 - 2025
        2. Erectile Dysfunction Drugs Market by Component type (USD Million), 2017 - 2025
        3. Erectile Dysfunction Drugs Market by Dosage Form (USD Million), 2017 - 2025
        4. Erectile Dysfunction Drugs Market by Distribution Channel (USD Million), 2017 - 2025
    6. Middle East & Africa
      1. Erectile Dysfunction Drugs Market by Product (USD Million), 2017 - 2025
      2. Erectile Dysfunction Drugs Market by Component type (USD Million), 2017 - 2025
      3. Erectile Dysfunction Drugs Market by Dosage Form (USD Million), 2017 - 2025
      4. Erectile Dysfunction Drugs Market by Distribution Channel (USD Million), 2017 - 2025
  9. Company Profiles
    1. Bayer AG
      1. Overview
      2. Financials
      3. Drug Type Benchmarking
      4. Recent Developments
    2. Pfizer
      1. Overview
      2. Financials
      3. Drug Type Benchmarking
      4. Recent Developments
    3. Eli Lilly & Co.,
      1. Overview
      2. Financials
      3. Drug Type Benchmarking
      4. Recent Developments
    4. Vivus, Inc.
      1. Overview
      2. Financials
      3. Drug Type Benchmarking
      4. Recent Developments
    5. S.K. Chemicals Co. Ltd.
      1. Overview
      2. Financials
      3. Drug Type Benchmarking
      4. Recent Developments
    6. Dong-A Pharmaceutical Co. Ltd
      1. Overview
      2. Financials
      3. Drug Type Benchmarking
      4. Recent Developments
    7. Meda Pharmaceuticals
      1. Overview
      2. Financials
      3. Drug Type Benchmarking
      4. Recent Developments
    8. Apricus Biosciences
      1. Overview
      2. Financials
      3. Drug Type Benchmarking
      4. Recent Developments

Report Content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Overview
    • Financials
    • Drug Type benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecasts from 2017 – 2025
  • Market revenue estimates for Product up to 2025
  • Market revenue estimates for Drug Type up to 2025
  • Market revenue estimates for dosage form up to 2025
  • Market revenue estimates for Distribution Channel up to 2025
  • Regional market size and forecast for Product up to 2025
  • Regional market size and forecast for Drug Type up to 2025
  • Regional market size and forecast for dosage form segments up to 2025
  • Regional market size and forecast for Distribution Channel segments up to 2025
  • Company financials

Request For customization

 

By using this form you agree with the storage and handling of your data by this website.

Speak to Analyst

 

By using this form you agree with the storage and handling of your data by this website.

Inquire Before Buying

 

By using this form you agree with the storage and handling of your data by this website.

Request for Sample


By using this form you agree with the storage and handling of your data by this website.